| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |
Arkansas Childrens Nutrition Center and Departments of Pediatrics [R. H., M. J. J. R., J. M. J., T. M. B.] and Pathology [S. K.], University of Arkansas for Medical Sciences, Little Rock, Arkansas 72202
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
48,000 would eventually die of the disease (1)
. Advances in early detection and surgery have been largely responsible for reducing mortality and morbidity of colon cancer, and our understanding of prevention is increasing. Epidemiological data suggest that diet is a major factor in the etiology of cancer. Metabolic phenotype, the Western-style diet (low dietary fiber and high levels of fat and red meat), and cooking techniques (e.g., charbroiling or overcooking) are risk factors for developing colon cancer (2 , 3) . For example, people who consume relatively high levels of well-cooked pan-fried or charred meats and who also have rapid metabolic phenotypes for cytochrome P4501A2 and slow metabolic phenotypes for acetyltransferase may be at increased risk for colon cancer (4) . Thus, reduced consumption of charred meats, especially in people who may be genetically predisposed to greater colorectal cancer risk because of their metabolic phenotype, may be important in lowering risk of colon cancer.
Moreover, epidemiological and animal studies suggest that diets low in animal fat and high in fruits, vegetables, grains, and legumes may protect against colon cancer. For example, diets containing soybeans and soybean-based products may reduce the risk of certain types of cancer, including breast, prostate, and colon cancer (5 , 6) . Data obtained from studies of Japanese subjects point to lower colon cancer incidence in areas with high tofu consumption (7) . Furthermore, several animal studies have suggested that diets containing certain vegetables, grains, or specific phytochemicals reduce the risks of experimentally induced colon cancer (8, 9, 10) .
In addition to the protective effects of certain phytochemicals, bovine milk products may exert inhibitory effects on the growth of several tumor types (11)
. An antitumor activity of these dairy products has been attributed to a class of proteins that represent 20% of the total milk protein, the whey fraction (12)
. Recently, Tsuda et al. (13)
reported that the major whey protein component, bovine lactoferrin, reduced the incidence and multiplicity of colon carcinoma in male rats. GSH3
concentrations in a number of tissues have been reported to increase in rats fed whey protein, and this is thought to be attributable to relatively high levels of
-glutamylcysteine groups, which serve as substrate for glutathione synthetase (11)
.
-Glutamylcysteine groups are considered extremely rare in edible proteins, with whey protein being one of the few such proteins containing the glutamylcysteine disulfide link (14)
. Increased tissue concentrations of GSH would be predicted to have a protective effect because elevated antioxidant capacity would favor decreased mutagenicity.
Recently, our laboratory has demonstrated that AIN-93G diets, which are rich in whey protein, reduced the incidence of chemically induced mammary tumors by 3846% compared with casein in female Sprague Dawley rats (6) . The present study was conducted to determine the possible preventive effects of lifetime exposure to whey proteins on AOM-induced colon tumors in male Sprague Dawley rats.
| Materials and Methods |
|---|
|
|
|---|
Two experiments were performed. In experiment A, pregnant female Sprague Dawley rats (gestation day 4) were randomly assigned to one of two groups and fed a modified AIN-93G diet (15) in which corn oil was substituted for soybean oil and the protein source of either casein or whey (New Zealand Milk Products, Santa Rosa, CA). Amino acids were added to both diets to equalize the essential amino acids. Male offspring (F1) were weaned to the same diets as their dams and were maintained on these diets throughout the study.
In experiment B, female rats were maintained on the diets described above for 4 weeks prior to breeding, and the offspring from these dams were weaned to the same diet as their mothers. Male and female offspring from different parents within a diet group were selected at random and mated to form the F2 generation. The F2 generation was studied to simulate people consuming the same basic diet for generations.
At age 90 days, all male offspring from experiments A and B received s.c. injections of 15 mg/kg AOM (Ash Stevens, Detroit, MI) in saline once a week for 2 weeks. All procedures were approved by the Institutional Animal Care and Use Committee at University of Arkansas for Medical Sciences, and AOM handling was in accordance with manufacturing and institutional guidelines. Rats were weighed weekly and observed daily during the first 30 days for signs of toxicity (i.e., fecal blood, altered fur coat appearance, anemia, and body weight gains). Forty weeks after the last AOM injection, all rats were euthanized, and the colon (cecum to anus) was divided into two equal segments (proximal and distal), opened longitudinally, washed free of contents with ice-cold saline, and examined visually for tumors. The locations, weights, and distribution of all tumors were recorded. A representative section of each tumor was fixed in 10% neutral-buffered formalin. Sections (5 µm) of the paraffin-embedded tumors were stained with H&E for histological analysis.
Pathology.
All tumors were evaluated in a blinded protocol by an American College of Pathology-certified pathologist (S. K.) and classified.
GSH Concentrations.
After the lifetime feeding of casein or whey, male (age, 65 days; n = 5) and female (age, 50 days; n = 5) rats were euthanized. The livers were removed, and cytosols were prepared by using the method of Chipman and Walker (16)
. Soluble protein was assessed using the Coomassie Brilliant Blue assay (Bio-Rad Laboratories, Hercules, CA) according to the manufacturers instructions, and cytosolic GSH concentrations were determined using a colorimetric kit (Oxis Int., Inc., Minneapolis, MN) according to the manufacturers instructions.
Statistical Analysis.
Fishers exact test was used to compare the percentage of rats with tumors in each treatment group. The nonparametric Mann-Whitney U test was used for comparing tumor multiplicity and weight of tumors. GSH levels were compared by t test. Statistical significance was set at P < 0.05. The technique described by Fisher (17)
was used to combine the probabilities from the two experiments.
| Results |
|---|
|
|
|---|
|
|
Although there was a clear trend toward reduced incidence (3242%) of tumors histologically identified as invasive adenocarcinoma (Fig. 2)
, the numbers of rats per group was too low to reach statistical significance (Table 1)
.
|
Although GSH levels were not determined in the experiment reported above, they were assessed in another set of male and female rats treated with the same diets. The GSH concentrations (µmol/mg of protein) did not differ significantly between diet or gender. The concentrations in male (n = 5) and female (n = 5) rats fed casein were 0.029 ± 0.002 and 0.031 ± 0.003 µmol/mg of protein, respectively, and concentrations in male (n = 5) and female (n = 5) rats fed the whey diet were 0.026 ± 0.002 and 0.026 ± 0.002 µmol/mg of protein, respectively.
| Discussion |
|---|
|
|
|---|
We recently demonstrated that female rats fed diets made with whey protein had significantly reduced incidence of chemically induced (dimethylbenz[a]anthracene) mammary tumors compared with rats fed casein diets (6)
. These data were consistent with the study of Papenburg et al. (18)
, who reported lower 1,2-dimethylhydrazine-induced colon tumor incidence and mass in mice fed whey protein than in mice fed either casein or a commercially available mouse diet. A recent report by Tsuda et al. (13)
demonstrated that bovine lactoferrin, a major whey protein component, inhibits colon carcinogenesis in male rats. The major aim of this study was to evaluate the chemopreventive effects of the whey protein diet against AOM-induced colon tumors in male Sprague Dawley rats. Our results indicate that rats fed a whey-containing diet had an
40% lower tumor incidence rate, but no significant differences were noted in the tumor mass and multiplicity.
The current study also histologically characterized the tumor type and segmented the colon into the proximal and distal sections to determine whether protective effects occurred equally for benign and invasive adenocarcinoma and to determine whether any regional differences existed. We found that the tumor incidence of invasive adenocarcinoma in the colon was 3242% lower in whey-fed rats than in casein-fed rats. Although the total number of rats studied in each group was substantial (3249 rats/group), the absolute numbers of rats that developed tumors for individual experiments were too small to permit detection of statistically significant effects of diet (whey versus casein) on tumor type (invasive adenocarcinoma versus benign) or colon location (proximal versus distal) within individual experiments. Analysis of combined treatment effects of experiments A and B revealed lower incidences of invasive adenocarcinoma tumors of the colon (P < 0.05), but it failed to detect differences between proximal and distal sites.
One possible explanation for lower percentages of rat with tumors in the present study could be the length of the post-AOM treatment in our experiments. Other investigators studying this colon cancer model used two s.c. doses of AOM and sacrificed rats 52 weeks post-AOM injection compared with the 40 weeks post-AOM that we used in this experiment (21 , 22) . This longer period would tend to increase the number of tumors detected.
The rats fed a whey protein diet had slightly lower weight gain than rats fed a casein diet for both experiments. Previous results from our laboratory have demonstrated that rats fed whey protein or soy had a tendency to gain less body weight than casein-fed rats and that food intake could not account for these differences (6) . The rate of body weight gain was lower in whey-fed rats between 50 and 90 days of age (P < 0.05), which led to a significant difference in absolute weight at end of the experiment (P < 0.05). However, the rate of body weight gain following administration of AOM did not differ significantly between groups. Because the whey-fed rats had excellent body weight gains within the normal range for rats fed standard rat feed, it is unlikely that the protective effects were linked to the slight differences in absolute body weight between groups.
One suggested mechanism for whey protection has been the reported increases in tissue GSH concentrations. One expected effect of increased tissue GSH levels would be increased detoxification of the free radicals produced by metabolism of carcinogenic and xenobiotic compounds (23)
. However, the hepatic GSH levels of rats fed whey protein- or casein protein-containing diets did not differ. Another possible mechanism involves altered procarcinogen activation/deactivation via phase I and phase II enzymes. In this regard, we have reported significant increases in dimethylbenz[a]anthracene-induced hepatic GST-
activities in female rats fed whey protein diets (24)
.
In summary, we studied the effects of whey protein on AOM-induced colon tumors in male rats. Rats fed a diet made from whey protein demonstrated protection against AOM-induced colonic tumor incidence compared with rats fed a casein-containing diet. These results suggest that long-term consumption of whey protein may reduce the risk of colon cancer. Further studies are under way in our laboratory to understand the mechanisms responsible for this protection.
| Acknowledgments |
|---|
| Footnotes |
|---|
1 Supported by a United States Department of Agriculture-Agriculture Research Service Arkansas Childrens Nutrition Center grant. ![]()
2 To whom requests for reprints should be addressed, at 1120 Marshall Street, Little Rock, AR 72202. Phone: (501) 320-2795; Fax: (501) 320-2818; E-mail: hakkakreza{at}uams.edu ![]()
3 The abbreviations used are: GSH, glutathione; AOM, azoxymethane. ![]()
Received 9/ 8/00; revised 1/24/01; accepted 1/30/01.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. C Larsson, L. Bergkvist, J. Rutegard, E. Giovannucci, and A. Wolk Calcium and dairy food intakes are inversely associated with colorectal cancer risk in the Cohort of Swedish Men Am. J. Clinical Nutrition, March 1, 2006; 83(3): 667 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pierre, A. Freeman, S. Tache, R. Van der Meer, and D. E. Corpet Beef Meat and Blood Sausage Promote the Formation of Azoxymethane-Induced Mucin-Depleted Foci and Aberrant Crypt Foci in Rat Colons J. Nutr., October 1, 2004; 134(10): 2711 - 2716. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |